Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 368

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies

Open access
Benjamin, Reuben, Graham, Charlotte, Yallop, Deborah, Jozwik, Agnieszka, Mirci-Danicar, Oana C, Lucchini, Giovanna, Pinner, Danielle, Jain, Nitin, Kantarjian, Hagop, Boissel, Nicolas, Maus, Marcela V, Frigault, Matthew J, Baruchel, André, Mohty, Mohamad, Gianella-Borradori, Athos, Binlich, Florence, Balandraud, Svetlana, Vitry, Fabien, Thomas, Elisabeth, Philippe, Anne, Fouliard, Sylvain, Dupouy, Sandra, Marchiq, Ibtissam, Almena-Carrasco, Maria, Ferry, Nicolas, Arnould, Sylvain, Konto, Cyril, Veys, Paul, Qasim, Waseem, Benjamin, Reuben, Graham, Charlotte, Yallop, Deborah, Jozwik, Agnieszka, Pagliuca, Antonio, Mufti, Ghulam, Patten, Piers, Kassam, Shireen, Devereux, Stephen, Kazmi, Majid, Cuthill, Kirsty, Potter, Victoria, Kuhnl, Andrea, Metaxa, Victoria, Bonganay, Laarni, Stewart, Orla, Ellard, Rose, Catt, Lorraine, Lewis, Jen, Farzaneh, Farzin, Chappell, Jackie, Mason, Alice, Chu, Vicky, Dunlop, Alan, Saleem, Adeel, Cheung, Gary, Munro, Helena, Giemza, Elka, Qasim, Waseem, Veys, Paul, Ciocarlie, Oana, Lucchini, Giovanna, Pinner, Danielle, Chu, Jan, Amrolia, Persis, Rao, Kanchan, Chiesa, Robert, Silva, Juliana, Hill, Annette, Finch, Maria, Young, Lindsey, Hara, Harvinder, Samarasinghe, Sujith, Rao, Anupama, Vora, Ajay, Gilmour, Kimberley, Rivat, Christine, Murphy, Clare, Ahsan, Gulrukh, Said Shamsah, Rasha, James, Jesmina, Inglott, Sarah, Wright, Gary, Adams, Stuart, Izotova, Natalia, Jain, Nitin, Konopleva, Marina, Wierda, William, Jabbour, Elias, Kantarjian, Hagop, Kebrieai, Partow, Jones, Emily, McGee, Kara, Maus, Marcela, Frigault, Matthew, Brown, Jami, Toncheva, Vesselina, Casey, Keagan, Hock, Hanno, McKeown, Meaghan A, Mathews, Richard, Spitzer, Thomas, Boissel, Nicolas, Raffoux, Emmanuel, Lengliné, Etienne, Itzykson, Raphael, Rabian, Florence, Larghero, Jérôme, Madelaine, Isabelle, Azoulay, Elie, Clappier, Emmanuelle, Caillat-Zucman, Sophie, Meunier, Martine, Celli-Lebras, Karine, Tremorin, Marie-Thérèse, Baruchel, André, Yakouben, Karima, Mechinaud-Heloury, Françoise, Grain, Audrey, Alimi, Aurélia, Roupret, Julie, Chaillou, Delphine, Larghero, Jérôme, Madelaine, Isabelle, Cavé, Hélène, Caye-Eude, Aurelie, Fenneteau, Odile, Lainey, Elodie, Naudin, Jerome, Mohty, Mohamad, Brissot, Eolia, Dulery, Remy, Malard, Florent, Mediavilla, Clémence, Bonnin, Agnès, Vekhoff, Anne, Ledraa, Tounes, Larghero, Jérôme, Daguenel-Nguyen, Anne·2020·The Lancet

Abstract

Background: Genome-edited donor-derived allogeneic anti-CD19 chimeric antigen receptor (CAR) T-cells offer an ‘off-the-shelf’ CAR T-cell product, broadening access and applicability. UCART19 is an innovative genome-edited donor-derived allogeneic CAR T-cell product investigated in children and adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (ALL). Methods: We enrolled paediatric or adult patients in two on-going phase I clinical trials to evaluate the safety and antileukaemic activity of UCART19. Patients underwent lymphodepletion with fludarabine and cyclophosphamide ± alemtuzumab, then children received UCART19 at 1·1 to 2·3×106 cells/kg and adults received UCART19 doses of 6×106, 6–8×107 or 1·8–2·4×108 cells in a dose-escalation study. These studies were registered at Clinicaltrials.gov (NCT02808442 and NCT02746952). Results: 7 children and 14 adults were enrolled in the two studies and received UCART19. Cytokine release syndrome (CRS) was the most common adverse event observed in 19 patients (91%); three (14%) had grade 3–4 CRS. Other adverse events were grade 1 or 2 neurotoxicity in eight patients (38%), grade 1 acute skin graft-versus-host disease in two patients (10%) and grade 4 prolonged cytopenia in six patients (29%). Two treatment-related deaths occurred; one caused by neutropenic sepsis in a patient with concurrent CRS and one from pulmonary haemorrhage in a patient with persistent cytopenia. The rate of complete remission or complete remission with incomplete hematologic recovery at day 28 post-infusion was 67%. Patients not receiving alemtuzumab (n=4 patients) showed no UCART19 expansion or antileukaemic activity. Interpretation: UCART19 exhibited in vivo expansion and anti-leukaemic activity with a manageable safety profile in heavily pretreated paediatric and adult patients with relapsed or refractory B-cell ALL. Funding: Servier

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(20)32334-5

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 368

Metadata

Authors
Benjamin, R., Graham, C., Yallop, D., Jozwik, A., Mirci-Danicar, O. C., Lucchini, G., Pinner, D., Jain, N., Kantarjian, H., Boissel, N., Maus, M. V., Frigault, M. J., Baruchel, A., Mohty, M., Gianella-Borradori, A., Binlich, F., Balandraud, S., Vitry, F., Thomas, E., Philippe, A., Fouliard, S., Dupouy, S., Marchiq, I., Almena-Carrasco, M., Ferry, N., Arnould, S., Konto, C., Veys, P., Qasim, W., Benjamin, R., Graham, C., Yallop, D., Jozwik, A., Pagliuca, A., Mufti, G., Patten, P., Kassam, S., Devereux, S., Kazmi, M., Cuthill, K., Potter, V., Kuhnl, A., Metaxa, V., Bonganay, L., Stewart, O., Ellard, R., Catt, L., Lewis, J., Farzaneh, F., Chappell, J., Mason, A., Chu, V., Dunlop, A., Saleem, A., Cheung, G., Munro, H., Giemza, E., Qasim, W., Veys, P., Ciocarlie, O., Lucchini, G., Pinner, D., Chu, J., Amrolia, P., Rao, K., Chiesa, R., Silva, J., Hill, A., Finch, M., Young, L., Hara, H., Samarasinghe, S., Rao, A., Vora, A., Gilmour, K., Rivat, C., Murphy, C., Ahsan, G., Said Shamsah, R., James, J., Inglott, S., Wright, G., Adams, S., Izotova, N., Jain, N., Konopleva, M., Wierda, W., Jabbour, E., Kantarjian, H., Kebrieai, P., Jones, E., McGee, K., Maus, M., Frigault, M., Brown, J., Toncheva, V., Casey, K., Hock, H., McKeown, M. A., Mathews, R., Spitzer, T., Boissel, N., Raffoux, E., Lengliné, E., Itzykson, R., Rabian, F., Larghero, J., Madelaine, I., Azoulay, E., Clappier, E., Caillat-Zucman, S., Meunier, M., Celli-Lebras, K., Tremorin, M.-T., Baruchel, A., Yakouben, K., Mechinaud-Heloury, F., Grain, A., Alimi, A., Roupret, J., Chaillou, D., Larghero, J., Madelaine, I., Cavé, H., Caye-Eude, A., Fenneteau, O., Lainey, E., Naudin, J., Mohty, M., Brissot, E., Dulery, R., Malard, F., Mediavilla, C., Bonnin, A., Vekhoff, A., Ledraa, T., Larghero, J., & Daguenel-Nguyen, A.
Venue
The Lancet
Publisher
Elsevier BV
Published
2020-12
Volume
396
Issue
10266
Pages
1885-1894
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W3113171896
Cited by
368
References
19
FWCI
15.72
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies. https://app.cochat.ai/papers/10.1016/s0140-6736(20)32334-5
The paper
Benjamin, R., Graham, C., Yallop, D., Jozwik, A., Mirci-Danicar, O. C., Lucchini, G., Pinner, D., Jain, N., Kantarjian, H., Boissel, N., Maus, M. V., Frigault, M. J., Baruchel, A., Mohty, M., Gianella-Borradori, A., Binlich, F., Balandraud, S., Vitry, F., Thomas, E., . . . Daguenel-Nguyen, A. (2020). Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies. The Lancet. https://doi.org/10.1016/s0140-6736(20)32334-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.